Literature DB >> 31922311

Evaluation of a Workflow to Define Low Specific Absorption Rate MRI Protocols for Patients With Active Implantable Medical Devices.

Jessica A Martinez1,2, Kévin Moulin3, Bryan Yoo2, Yu Shi2, Hyun J Kim2, Pablo J Villablanca2, Daniel B Ennis3.   

Abstract

BACKGROUND: MRI exams for patients with MR-conditional active implantable medical devices (AIMDs) are contraindicated unless specific conditions are met. This limits the maximum specific absorption rate (SAR, W/kg). Currently, there is no general framework to guide meeting a lower SAR limit.
PURPOSE: To design and evaluate a workflow for modifying MRI protocols to whole-body SAR (WB-SAR ≤0.1 W/kg) and local-head SAR (LH-SAR ≤0.3 W/kg) limits while mitigating the impact on image quality and exam time. STUDY TYPE: Prospective. POPULATION: Twenty healthy volunteers on head (n = 5), C-spine (n = 5), T-spine (n = 5), and L-spine (n = 5) with IRB consent. ASSESSMENT: Vendor-provided head, C-spine, T-spine, and L-spine protocols (SARRT ) were modified to meet both low SAR targets (SARLOW ) using the proposed workflow. in vitro SNR and CNR were evaluated with a T1 -T2 phantom. in vivo image quality and clinical acceptability were scored using a 5-point Likert scale for two blinded readers. FIELD STRENGTH/SEQUENCES: 1.5T/spin-echoes, gradient-echoes. STATISTICAL ANALYSIS: In vitro SNR and CNR values were evaluated with a repeated measures general linear model. in vivo image quality and clinical acceptability were evaluated using a generalized estimating equation analysis (GEE). The two reader's level of agreement was analyzed using Cohen's kappa statistical analysis.
RESULTS: Using the workflow, SAR limits were met. LH-SAR: 0.12 ± 0.02 W/kg, median (SD) values for LH-SAR were 0.12 (0.02) W/kg and WB-SAR: 0.09 (0.01) W/kg. Examination time did not increase ≤2x the initial time. SARRT SNR values were higher and significantly different than SARLOW (P < 0.05). However, no significant difference was observed between the CNR values (value = 0.21). Median (IQR) CNR values were 14.2 (25.0) vs. 15.1 (9.2) for head, 12.1 (16.9) vs. 25.3 (14.2) for C-spine, 81.6 (70.1) vs. 71.0 (26.6) for T-spine, and 51.4 (52.6) vs. 37.7 (27.3) for L-spine. Image quality scores were not significantly different between SARRT and SARLOW (median [SD] scores were 4.0 [0.01] vs. 4.3 [0.2], P > 0.05). DATA
CONCLUSION: The proposed workflow provides guidance for modifying routine MRI exams to achieve low SAR limits. This can benefit patients referred for an MRI exam with low SAR MR-conditional AIMDs. LEVEL OF EVIDENCE: 1 Technical Efficacy Stage: 5 J. Magn. Reson. Imaging 2020;52:91-102.
© 2020 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  MR-conditional; MR-safety; MRI; SAR; active implantable medical devices; low SAR

Mesh:

Year:  2020        PMID: 31922311      PMCID: PMC8166235          DOI: 10.1002/jmri.27044

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  20 in total

1.  MR imaging in patients with pacemakers and other devices: engineering the future.

Authors:  Jerold S Shinbane; Patrick M Colletti; Frank G Shellock
Journal:  JACC Cardiovasc Imaging       Date:  2012-03

2.  Clinical safety of brain magnetic resonance imaging with implanted deep brain stimulation hardware: large case series and review of the literature.

Authors:  Ludvic Zrinzo; Fumiaki Yoshida; Marwan I Hariz; John Thornton; Thomas Foltynie; Tarek A Yousry; Patricia Limousin
Journal:  World Neurosurg       Date:  2011 Jul-Aug       Impact factor: 2.104

3.  Practical approaches to the evaluation of signal-to-noise ratio performance with parallel imaging: application with cardiac imaging and a 32-channel cardiac coil.

Authors:  Scott B Reeder; Bernd J Wintersperger; Olaf Dietrich; Titus Lanz; Andreas Greiser; Maximilian F Reiser; Gary M Glazer; Stefan O Schoenberg
Journal:  Magn Reson Med       Date:  2005-09       Impact factor: 4.668

4.  Toward individualized SAR models and in vivo validation.

Authors:  H Homann; P Börnert; H Eggers; K Nehrke; O Dössel; I Graesslin
Journal:  Magn Reson Med       Date:  2011-05-31       Impact factor: 4.668

5.  Brain MR imaging at ultra-low radiofrequency power.

Authors:  Subhendra N Sarkar; David C Alsop; Ananth J Madhuranthakam; Reed F Busse; Philip M Robson; Neil M Rofsky; David B Hackney
Journal:  Radiology       Date:  2011-02-25       Impact factor: 11.105

6.  [Explanation of JIS T 62570 Standard Practice for Marking Medical Devices and Other Items for Safety in the Magnetic Resonance Environment].

Authors:  Toru Shimizu
Journal:  Nihon Hoshasen Gijutsu Gakkai Zasshi       Date:  2018

7.  Optimized, Minimal Specific Absorption Rate MRI for High-Resolution Imaging in Patients with Implanted Deep Brain Stimulation Electrodes.

Authors:  A M Franceschi; G C Wiggins; A Y Mogilner; T Shepherd; S Chung; Y W Lui
Journal:  AJNR Am J Neuroradiol       Date:  2016-07-14       Impact factor: 3.825

8.  T1 and T2 measurements on a 1.5-T commercial MR imager.

Authors:  R K Breger; A A Rimm; M E Fischer; R A Papke; V M Haughton
Journal:  Radiology       Date:  1989-04       Impact factor: 11.105

9.  The Safety of Using Body-Transmit MRI in Patients with Implanted Deep Brain Stimulation Devices.

Authors:  Joshua Kahan; Anastasia Papadaki; Mark White; Laura Mancini; Tarek Yousry; Ludvic Zrinzo; Patricia Limousin; Marwan Hariz; Tom Foltynie; John Thornton
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

10.  T1- vs. T2-based MRI measures of spinal cord volume in healthy subjects and patients with multiple sclerosis.

Authors:  Gloria Kim; Fariha Khalid; Vinit V Oommen; Shahamat Tauhid; Renxin Chu; Mark A Horsfield; Brian C Healy; Rohit Bakshi
Journal:  BMC Neurol       Date:  2015-07-31       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.